Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study von Lopez Lopez, R., Reina Zoilo, J.J., Monge, D., Caballero, F., Guillem Porta, V., Aranda Aguilar, E., Carrato Mena, A., Diaz Rubio, E., Garcia Foncillas, J., Feyjoo, M., Camps, C.

Volltext

Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP) von Camps Herrero, C., Reina Zoilo, J. J., Monge Martín, D., Caballero Martínez, F., Guillem Porta, V., Aranda Aguilar, E., Carrato Mena, A., Díaz-Rubio García, E., García-Foncillas López, J., Feijóo Saus, M., López López, R.

Volltext

P-3 Real-world dosing patterns of regorafenib in patients with metastatic colorectal cancer in Spain: The RE-SEARCH study von Muñoz, A. López, González-Flores, E., Afonso, R., Maseda, A. Carral, Pimentel, P., López-López, C., Jimeno, R., Mateos, R. Fuentes, Zoilo, J. Reina

Volltext

P-60 Doxycycline as preventive treatment of skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy von Ramirez Daffos, P., Jiménez, E., Bolaños Naranjo, M., González-Astorga, B., Rubiales, S., Ceballos Barbancho, E., Rodríguez, J., Reina Zoilo, J.

Volltext

P-50 Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study von García-Alfonso, P., Reina Zoilo, J., Mata Velasco, E., Llanos, M., Illán Varella, A., Safont Aguilera, M., Delgado Ureña, M., Castañón, C., Pimentel, P., Alonso Orduña, V., Mendez, J., Rivera Herrero, F., Siso, I., Rodriguez-Pascual, J., Grávalos Castro, C., Afonso, R., Fernandez Rañada, I., Grández, R., Moreno, M., López Muñoz, A., García-Paredes, B., Aranda, E.

Volltext

1709PAssessment and treatment of breakthrough cancer pain in Spain: A self-audit study von Lopez Lopez, R, Reina Zoilo, J J, Monge, D, Caballero, F, Guillem Porta, V, Aranda Aguilar, E, Carrato Mena, A, Diaz Rubio, E, Garcia Foncillas, J, Feyjoo, M, Camps, C

Volltext

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma... von Sastre, J., García-Alfonso, P., Viéitez, J.M., Cano, M.T., Rivera, F., Reina-Zoilo, J.J., Salud-Salvia, A., Quintero, G., Robles-Díaz, L., Safont, M.J., La Casta, A., Gil, S., Polo, E., Asensio-Martínez, E., García-Paredes, B., López, R.L., Guillot, M., Valladares-Ayerbes, M., Aranda, E., Díaz-Rubio, E., Viéitez, J.M., Jiménez, P., Aguilar, E. Aranda, Gómez, A., Gil Calle, S., Salud, A., Valladares, M., Graña, B., García-Alfonso, P., Rivera, F., Quintero, G., Reina, J.J., González Flores, E., Salgado, M., Grande, E., Guillén, C., Garcia Carbonero, R., Flor, M.J., Safont, M.J., La Casta, A., Arévalo, S., Sastre, J., López López, R., Manzano, H., Guillot, M., Hernández Yagüe, X., Arrivi, A., Falcó, E., Gallego, J., Escudero, P., Cabezas, I., Juárez, A., Gálvez, E., Grávalos, C., Robles, L., Polo, E., Dueñas, R., Campos, J.M., Albert, A., Salinas, P., Montagut, C., Provencio, M., Ruiz Casado, A., Muñoz, J., Gil Raga, M., Chilet, M.R., González González, F.J., Massutí, B., López, A., Aparicio, J., Marín, M., Alfaro, J., Zanui, M., Gutiérrez Abad, D., García Tapiador, A.M., García-Girón, C., Molina Saera, J., Torres Sánchez, E., López, I., Bosch, C., Valero, J., Martínez de Prado, P.

Volltext

593PDihydropyrimidine dehydrogenase (DPD) determination prior the administration of medicines containing fluorouracil: A single Spanish hospital experience von Rambla, M D Mediano, Marcos, J A, Carrillo, R, Espinosa, M, Sanchez, F, Alvardado, M D, Rendon, L, Zoilo, J J Reina, Albero, A

Volltext

Dihydropyrimidine dehydrogenase (DPD) determination prior the administration of medicines containing fluorouracil: A single Spanish hospital experience von Rambla, M D Mediano, Marcos, J.A., Carrillo, R., Espinosa, M., Sanchez, F., Alvardado, M.D., Rendon, L., Zoilo, J J Reina, Albero, A.

Volltext

593P - Dihydropyrimidine dehydrogenase (DPD) determination prior the administration of medicines containing fluorouracil: A single Spanish hospital experience von Rambla, M D Mediano, Marcos, J.A., Carrillo, R., Espinosa, M., Sanchez, F., Alvardado, M.D., Rendon, L., Zoilo, J J Reina, Albero, A.

Volltext

Effectiveness and safety of imatinib in seven gastrointestinal stromal tumor cases von Giménez Castellanos, J, Sánchez Gómez, E, Reina Zoiló, J J, Gabella Bazarot, E, Marín Ariza, I, Grutzmancher Saiz, S

Volltext

560MO Maintenance with 5FU/LV-Aflibercept after induction with FOLFIRI-Aflibercept vs FOLFIRI-Aflibercept until progression in older patients (pts) in 2nd line metastatic colorecta... von García Alfonso, P., Elez Fernandez, M.E., Soto Alsar, J., Paez, D., Fernandez Montes, A., Grana Suarez, B., Salud, A., Yubero Esteban, A., Gomez España, M.A., Macias Declara, I., Quintero Aldana, G.A., Lopez Lopez, C., Fernandez Rodriguez, T., Gravalos Castro, M.C., González-Flores, E., Guix Arnau, M., García Paredes, B., Reina Zoilo, J.J., Sastre Varela, J., Aranda Aguilar, E.

Volltext

Efectividad y seguridad de imatinib en siete casos de tumores del estroma gastrointestinal von Giménez Castellanos, J., Sánchez Gómez, E., Reina Zoiló, J.J., Gabella Bazarot, E., Marín Ariza, I., Grutzmancher Saiz, S.

Volltext